Cost Effectiveness of Bevacizumab Plus Chemotherapy for the Treatment of Advanced and Metastatic Cervical Cancer in India—A Model-Based Economic Analysis.

Saved in:
Bibliographic Details
Title: Cost Effectiveness of Bevacizumab Plus Chemotherapy for the Treatment of Advanced and Metastatic Cervical Cancer in India—A Model-Based Economic Analysis.
Authors: Gupta, Nidhi1 (AUTHOR), Nehra, Prerika2 (AUTHOR), Chauhan, Akashdeep Singh2 (AUTHOR), Mehra, Nikita3 (AUTHOR), Singh, Ashish4 (AUTHOR), Krishnamurthy, Manjunath Nookala5 (AUTHOR), Rajsekhar, Kavitha6 (AUTHOR), Kalaiyarasi, Jayachandran Perumal3 (AUTHOR), Roy, Partha Sarathi7 (AUTHOR), Malik, Prabhat Singh8 (AUTHOR), Mathew, Anisha8 (AUTHOR), Malhotra, Pankaj9 (AUTHOR), Kataki, Amal Chandra10 (AUTHOR), Dixit, Jyoti2 (AUTHOR), Gupta, Sudeep11 (AUTHOR), Kumar, Lalit8 (AUTHOR), Prinja, Shankar2 (AUTHOR) shankarprinja@gmail.com
Source: JCO Global Oncology. 3/14/2022, Vol. 8, p1-10. 10p.
Database: Academic Search Ultimate
Description
ISSN:26878941
DOI:10.1200/GO.21.00355